J. Cogswell

674 total citations
22 papers, 557 citations indexed

About

J. Cogswell is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, J. Cogswell has authored 22 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in J. Cogswell's work include Prostate Cancer Treatment and Research (10 papers), Cancer, Lipids, and Metabolism (8 papers) and Cancer survivorship and care (8 papers). J. Cogswell is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Cancer, Lipids, and Metabolism (8 papers) and Cancer survivorship and care (8 papers). J. Cogswell collaborates with scholars based in United States, Spain and Japan. J. Cogswell's co-authors include Basil Kasimis, Victor T. Chang, Shirley S. Hwang, Shanthi Srinivas, Diane L. Fairclough, Charles Scott, Ronald M. Bukowski, Panos Fidias, Geoffrey I. Shapiro and Saby George and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

J. Cogswell

20 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Cogswell United States 9 311 232 143 133 87 22 557
Annemarie Coolbrandt Belgium 16 368 1.2× 259 1.1× 196 1.4× 132 1.0× 79 0.9× 37 682
Monika Sztankay Austria 16 395 1.3× 150 0.6× 149 1.0× 121 0.9× 67 0.8× 50 648
Sobha Kurian United States 10 341 1.1× 276 1.2× 195 1.4× 79 0.6× 37 0.4× 20 626
Nicole Horevoorts Netherlands 9 460 1.5× 161 0.7× 175 1.2× 112 0.8× 105 1.2× 16 717
Daan Brandenbarg Netherlands 16 361 1.2× 173 0.7× 133 0.9× 101 0.8× 49 0.6× 38 551
Anne Kvikstad Norway 10 404 1.3× 187 0.8× 237 1.7× 112 0.8× 142 1.6× 14 675
Lynn Batehup United Kingdom 11 312 1.0× 132 0.6× 141 1.0× 60 0.5× 75 0.9× 16 553
Risa Liang Wong United States 12 378 1.2× 278 1.2× 104 0.7× 112 0.8× 37 0.4× 38 686
Carl Michael Baravelli Norway 12 507 1.6× 273 1.2× 307 2.1× 111 0.8× 154 1.8× 28 774
Matthias Villalobos Germany 13 427 1.4× 550 2.4× 296 2.1× 111 0.8× 61 0.7× 50 899

Countries citing papers authored by J. Cogswell

Since Specialization
Citations

This map shows the geographic impact of J. Cogswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Cogswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Cogswell more than expected).

Fields of papers citing papers by J. Cogswell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Cogswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Cogswell. The network helps show where J. Cogswell may publish in the future.

Co-authorship network of co-authors of J. Cogswell

This figure shows the co-authorship network connecting the top 25 collaborators of J. Cogswell. A scholar is included among the top collaborators of J. Cogswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Cogswell. J. Cogswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kasimis, Basil, et al.. (2009). Prediction of survival by immunohistochemical stains (IHC) in stage D2 prostate cancer patients (pts): The importance of pTEN overexpression. Journal of Clinical Oncology. 27(15_suppl). e16019–e16019. 1 indexed citations
3.
George, Saby, Basil Kasimis, J. Cogswell, et al.. (2008). Phase I Study of Flavopiridol in Combination with Paclitaxel and Carboplatin in Patients with Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 9(3). 160–165. 35 indexed citations
4.
Zhong, Fengming, et al.. (2006). A phase II trial of epirubicin (E), estramustine phosphate (EP), and celecoxib (C) as second line treatment of patients (pts) with hormone resistant prostate cancer (HRPC). Journal of Clinical Oncology. 24(18_suppl). 14567–14567. 2 indexed citations
5.
Kasimis, Basil, et al.. (2006). Combination therapy with docetaxel (D) and celecoxib (C) in patients (pts) with hormone resistant prostate cancer (HRPC). Journal of Clinical Oncology. 24(18_suppl). 14519–14519.
6.
Cogswell, J., et al.. (2005). Side Effects and Good Effects from New Chemotherapeutic Agents. Journal of Clinical Oncology. 23(10). 2423–2424. 34 indexed citations
7.
Zhong, Fengming, Basil Kasimis, Sean Hwang, et al.. (2005). Second line treatment of hormone resistant prostate cancer (HRPC). A phase II trial of epirubicin (E), estramustine phosphate (EP) and celecoxib (C). Journal of Clinical Oncology. 23(16_suppl). 4754–4754. 1 indexed citations
8.
Kasimis, Basil, et al.. (2005). High dose celecoxib (C) and docetaxel (D) in patients (pts) with hormone resistant prostate cancer (HRPC). Results of an ongoing phase II trial. Journal of Clinical Oncology. 23(16_suppl). 4704–4704. 5 indexed citations
9.
Madan, Ravi A., Victor T. Chang, Fengming Zhong, et al.. (2005). Prognostic value of soft tissue metastasis (STM) in stage D2 and stage D3 prostate Cancer (PC). Journal of Clinical Oncology. 23(16_suppl). 4720–4720. 3 indexed citations
10.
Hwang, Shirley S., et al.. (2004). Study of unmet needs in symptomatic veterans with advanced cancer: incidence, independent predictors and unmet needs outcome model. Journal of Pain and Symptom Management. 28(5). 421–432. 87 indexed citations
11.
Hwang, Shirley S., Charles Scott, Victor T. Chang, et al.. (2004). Prediction of Survival for Advanced Cancer Patients by Recursive Partitioning Analysis: Role of Karnofsky Performance Status, Quality of Life, and Symptom Distress. Cancer Investigation. 22(5). 678–687. 74 indexed citations
12.
Hwang, Shirley S., et al.. (2004). Study of Hormone Refractory Prostate Cancer: Hospital Care and Palliative Care Resource Use at a VA Medical Center. Cancer Investigation. 22(6). 849–857. 20 indexed citations
13.
Kasimis, Basil, et al.. (2004). Phase II trial of docetaxel (D) and high-dose celecoxib (C) in patients (Pts) with hormone resistant prostate cancer (HRPC). Journal of Clinical Oncology. 22(14_suppl). 4616–4616. 2 indexed citations
14.
Hwang, Shirley S., Victor T. Chang, Diane L. Fairclough, J. Cogswell, & Basil Kasimis. (2003). Longitudinal Quality of Life in Advanced Cancer Patients. Journal of Pain and Symptom Management. 25(3). 225–235. 100 indexed citations
15.
Hwang, Shirley S., Victor T. Chang, J. Cogswell, Shanthi Srinivas, & Basil Kasimis. (2003). Knowledge and attitudes toward end-of-life care in veterans with symptomatic metastatic cancer. Palliative & Supportive Care. 1(3). 221–230. 16 indexed citations
16.
Hwang, Shirley S., et al.. (2003). Caregiver unmet needs, burden, and satisfaction in symptomatic advanced cancer patients at a Veterans Affairs (VA) medical center. Palliative & Supportive Care. 1(4). 319–329. 102 indexed citations
17.
18.
Hwang, Shirley S., Victor T. Chang, J. Cogswell, & Basil Kasimis. (2002). Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center. Cancer. 94(9). 2481–2489. 65 indexed citations
19.
Hwang, Shirley S., Victor T. Chang, J. Cogswell, & Basil Kasimis. (2002). Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center. Cancer. 94(9). 2481–2489. 1 indexed citations
20.
Kasimis, Basil, George Wilding, Martin Feuerman, et al.. (2000). Survival of Patients Who Had Salvage Castration After Failure on Bicalutamide Monotherapy for Stage (D2) Prostate Cancer. Cancer Investigation. 18(7). 602–608. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annemarie Coolbrandt Breakdown of academic impact, for papers by Monika Sztankay Breakdown of academic impact, for papers by Sobha Kurian Breakdown of academic impact, for papers by Nicole Horevoorts Breakdown of academic impact, for papers by Daan Brandenbarg Breakdown of academic impact, for papers by Anne Kvikstad Breakdown of academic impact, for papers by Lynn Batehup Breakdown of academic impact, for papers by Risa Liang Wong Breakdown of academic impact, for papers by Carl Michael Baravelli Breakdown of academic impact, for papers by Matthias Villalobos
Rankless by CCL
2026